| Jefferson Urgent Care | |
|
84 Somerset Blvd Charles Town WV 25414-4827 | |
| (304) 728-8543 | |
| (304) 728-8644 |
| Full Name | Jefferson Urgent Care |
|---|---|
| Speciality | General Practice |
| Location | 84 Somerset Blvd, Charles Town, West Virginia |
| Authorized Official Name and Position | Sean Patrick Rhoads (OWNER) |
| Authorized Official Contact | 3047288543 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Jefferson Urgent Care 84 Somerset Blvd Charles Town WV 25414-4827 Ph: (304) 728-8543 | Jefferson Urgent Care 84 Somerset Blvd Charles Town WV 25414-4827 Ph: (304) 728-8543 |
| NPI Number | 1992726236 |
|---|---|
| Provider Enumeration Date | 07/22/2006 |
| Last Update Date | 04/02/2020 |
| Medicare PECOS PAC ID | 7315859535 |
|---|---|
| Medicare Enrollment ID | O20031105000141 |
News Archive
As doctors, scientists and governments try to get a grip on COVID-19, the University of Michigan startup Arbor Biosciences is providing free kits to capture the genetic code of virus samples.
Bio2 Technologies, Inc. (a privately held development stage company) announced today that it has received 510(k) clearance from the U.S. Food and Drug Administration for its CLM Bioactive Scaffold.
The font type of written text and how easy it is to read can be influential when it comes to engaging people with important health information and recruiting them for potentially beneficial programmes, new research by The University of Manchester and Leeds Beckett University has found.
Women with chronic kidney disease receive dialysis treatment far less often than men. However, women suffer more commonly than men from kidney disease. A publication by the MedUni Vienna and the Arbor Research Collaborative for Health, USA, has highlighted this difference based on international patient data.
CVRx, Inc., a private medical device company, announced the first patient enrolled in the Barostim HOPE4HF clinical trial. The study is evaluating the effectiveness and safety of CVRx's Barostim neo in heart failure patients.
› Verified 7 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1992726236 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208D00000X | General Practice | (* (Not Available)) | Primary |
| 261QU0200X | Clinic/center - Urgent Care | (* (Not Available)) | Secondary |
| Provider Name | Shannon K Bentley |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1033179817 PECOS PAC ID: 2264489376 Enrollment ID: I20060123000481 |
News Archive
As doctors, scientists and governments try to get a grip on COVID-19, the University of Michigan startup Arbor Biosciences is providing free kits to capture the genetic code of virus samples.
Bio2 Technologies, Inc. (a privately held development stage company) announced today that it has received 510(k) clearance from the U.S. Food and Drug Administration for its CLM Bioactive Scaffold.
The font type of written text and how easy it is to read can be influential when it comes to engaging people with important health information and recruiting them for potentially beneficial programmes, new research by The University of Manchester and Leeds Beckett University has found.
Women with chronic kidney disease receive dialysis treatment far less often than men. However, women suffer more commonly than men from kidney disease. A publication by the MedUni Vienna and the Arbor Research Collaborative for Health, USA, has highlighted this difference based on international patient data.
CVRx, Inc., a private medical device company, announced the first patient enrolled in the Barostim HOPE4HF clinical trial. The study is evaluating the effectiveness and safety of CVRx's Barostim neo in heart failure patients.
› Verified 7 days ago
| Provider Name | Peggy L Carlson |
|---|---|
| Provider Type | Practitioner - Emergency Medicine |
| Provider Identifiers | NPI Number: 1285955732 PECOS PAC ID: 5193628196 Enrollment ID: I20111005000949 |
News Archive
As doctors, scientists and governments try to get a grip on COVID-19, the University of Michigan startup Arbor Biosciences is providing free kits to capture the genetic code of virus samples.
Bio2 Technologies, Inc. (a privately held development stage company) announced today that it has received 510(k) clearance from the U.S. Food and Drug Administration for its CLM Bioactive Scaffold.
The font type of written text and how easy it is to read can be influential when it comes to engaging people with important health information and recruiting them for potentially beneficial programmes, new research by The University of Manchester and Leeds Beckett University has found.
Women with chronic kidney disease receive dialysis treatment far less often than men. However, women suffer more commonly than men from kidney disease. A publication by the MedUni Vienna and the Arbor Research Collaborative for Health, USA, has highlighted this difference based on international patient data.
CVRx, Inc., a private medical device company, announced the first patient enrolled in the Barostim HOPE4HF clinical trial. The study is evaluating the effectiveness and safety of CVRx's Barostim neo in heart failure patients.
› Verified 7 days ago
| Provider Name | Melissa M Leplatt |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1861713356 PECOS PAC ID: 9739323353 Enrollment ID: I20130923000381 |
News Archive
As doctors, scientists and governments try to get a grip on COVID-19, the University of Michigan startup Arbor Biosciences is providing free kits to capture the genetic code of virus samples.
Bio2 Technologies, Inc. (a privately held development stage company) announced today that it has received 510(k) clearance from the U.S. Food and Drug Administration for its CLM Bioactive Scaffold.
The font type of written text and how easy it is to read can be influential when it comes to engaging people with important health information and recruiting them for potentially beneficial programmes, new research by The University of Manchester and Leeds Beckett University has found.
Women with chronic kidney disease receive dialysis treatment far less often than men. However, women suffer more commonly than men from kidney disease. A publication by the MedUni Vienna and the Arbor Research Collaborative for Health, USA, has highlighted this difference based on international patient data.
CVRx, Inc., a private medical device company, announced the first patient enrolled in the Barostim HOPE4HF clinical trial. The study is evaluating the effectiveness and safety of CVRx's Barostim neo in heart failure patients.
› Verified 7 days ago
| Provider Name | Jason Bryce Swalm |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1962745950 PECOS PAC ID: 6800198516 Enrollment ID: I20160805000263 |
News Archive
As doctors, scientists and governments try to get a grip on COVID-19, the University of Michigan startup Arbor Biosciences is providing free kits to capture the genetic code of virus samples.
Bio2 Technologies, Inc. (a privately held development stage company) announced today that it has received 510(k) clearance from the U.S. Food and Drug Administration for its CLM Bioactive Scaffold.
The font type of written text and how easy it is to read can be influential when it comes to engaging people with important health information and recruiting them for potentially beneficial programmes, new research by The University of Manchester and Leeds Beckett University has found.
Women with chronic kidney disease receive dialysis treatment far less often than men. However, women suffer more commonly than men from kidney disease. A publication by the MedUni Vienna and the Arbor Research Collaborative for Health, USA, has highlighted this difference based on international patient data.
CVRx, Inc., a private medical device company, announced the first patient enrolled in the Barostim HOPE4HF clinical trial. The study is evaluating the effectiveness and safety of CVRx's Barostim neo in heart failure patients.
› Verified 7 days ago
| Provider Name | Jean L Bridwell |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1104992965 PECOS PAC ID: 0446591929 Enrollment ID: I20190410001180 |
News Archive
As doctors, scientists and governments try to get a grip on COVID-19, the University of Michigan startup Arbor Biosciences is providing free kits to capture the genetic code of virus samples.
Bio2 Technologies, Inc. (a privately held development stage company) announced today that it has received 510(k) clearance from the U.S. Food and Drug Administration for its CLM Bioactive Scaffold.
The font type of written text and how easy it is to read can be influential when it comes to engaging people with important health information and recruiting them for potentially beneficial programmes, new research by The University of Manchester and Leeds Beckett University has found.
Women with chronic kidney disease receive dialysis treatment far less often than men. However, women suffer more commonly than men from kidney disease. A publication by the MedUni Vienna and the Arbor Research Collaborative for Health, USA, has highlighted this difference based on international patient data.
CVRx, Inc., a private medical device company, announced the first patient enrolled in the Barostim HOPE4HF clinical trial. The study is evaluating the effectiveness and safety of CVRx's Barostim neo in heart failure patients.
› Verified 7 days ago
| Provider Name | Cathi Virginia George |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1508027707 PECOS PAC ID: 8022176932 Enrollment ID: I20200701001897 |
News Archive
As doctors, scientists and governments try to get a grip on COVID-19, the University of Michigan startup Arbor Biosciences is providing free kits to capture the genetic code of virus samples.
Bio2 Technologies, Inc. (a privately held development stage company) announced today that it has received 510(k) clearance from the U.S. Food and Drug Administration for its CLM Bioactive Scaffold.
The font type of written text and how easy it is to read can be influential when it comes to engaging people with important health information and recruiting them for potentially beneficial programmes, new research by The University of Manchester and Leeds Beckett University has found.
Women with chronic kidney disease receive dialysis treatment far less often than men. However, women suffer more commonly than men from kidney disease. A publication by the MedUni Vienna and the Arbor Research Collaborative for Health, USA, has highlighted this difference based on international patient data.
CVRx, Inc., a private medical device company, announced the first patient enrolled in the Barostim HOPE4HF clinical trial. The study is evaluating the effectiveness and safety of CVRx's Barostim neo in heart failure patients.
› Verified 7 days ago
| Provider Name | Carlyn M Russell |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1306496856 PECOS PAC ID: 9133554405 Enrollment ID: I20220112002653 |
News Archive
As doctors, scientists and governments try to get a grip on COVID-19, the University of Michigan startup Arbor Biosciences is providing free kits to capture the genetic code of virus samples.
Bio2 Technologies, Inc. (a privately held development stage company) announced today that it has received 510(k) clearance from the U.S. Food and Drug Administration for its CLM Bioactive Scaffold.
The font type of written text and how easy it is to read can be influential when it comes to engaging people with important health information and recruiting them for potentially beneficial programmes, new research by The University of Manchester and Leeds Beckett University has found.
Women with chronic kidney disease receive dialysis treatment far less often than men. However, women suffer more commonly than men from kidney disease. A publication by the MedUni Vienna and the Arbor Research Collaborative for Health, USA, has highlighted this difference based on international patient data.
CVRx, Inc., a private medical device company, announced the first patient enrolled in the Barostim HOPE4HF clinical trial. The study is evaluating the effectiveness and safety of CVRx's Barostim neo in heart failure patients.
› Verified 7 days ago
| Provider Name | Ashlyn S Andres |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1730581307 PECOS PAC ID: 5799090171 Enrollment ID: I20220421002628 |
News Archive
As doctors, scientists and governments try to get a grip on COVID-19, the University of Michigan startup Arbor Biosciences is providing free kits to capture the genetic code of virus samples.
Bio2 Technologies, Inc. (a privately held development stage company) announced today that it has received 510(k) clearance from the U.S. Food and Drug Administration for its CLM Bioactive Scaffold.
The font type of written text and how easy it is to read can be influential when it comes to engaging people with important health information and recruiting them for potentially beneficial programmes, new research by The University of Manchester and Leeds Beckett University has found.
Women with chronic kidney disease receive dialysis treatment far less often than men. However, women suffer more commonly than men from kidney disease. A publication by the MedUni Vienna and the Arbor Research Collaborative for Health, USA, has highlighted this difference based on international patient data.
CVRx, Inc., a private medical device company, announced the first patient enrolled in the Barostim HOPE4HF clinical trial. The study is evaluating the effectiveness and safety of CVRx's Barostim neo in heart failure patients.
› Verified 7 days ago
News Archive
As doctors, scientists and governments try to get a grip on COVID-19, the University of Michigan startup Arbor Biosciences is providing free kits to capture the genetic code of virus samples.
Bio2 Technologies, Inc. (a privately held development stage company) announced today that it has received 510(k) clearance from the U.S. Food and Drug Administration for its CLM Bioactive Scaffold.
The font type of written text and how easy it is to read can be influential when it comes to engaging people with important health information and recruiting them for potentially beneficial programmes, new research by The University of Manchester and Leeds Beckett University has found.
Women with chronic kidney disease receive dialysis treatment far less often than men. However, women suffer more commonly than men from kidney disease. A publication by the MedUni Vienna and the Arbor Research Collaborative for Health, USA, has highlighted this difference based on international patient data.
CVRx, Inc., a private medical device company, announced the first patient enrolled in the Barostim HOPE4HF clinical trial. The study is evaluating the effectiveness and safety of CVRx's Barostim neo in heart failure patients.
› Verified 7 days ago
West Virginia University Medical Corporation Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 710 Somerset Blvd Ste 100, Charles Town, WV 25414 Phone: 304-728-9797 Fax: 304-728-9791 | |
University Urgent Care Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 912 Somerset Blvd, Ste 102, Charles Town, WV 25414 Phone: 304-725-2273 Fax: 304-724-0053 | |
Shenandoah Valley Medical System,inc. Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 44 Trifecta Pl Ste 205, Charles Town, WV 25414 Phone: 304-728-3716 Fax: 304-278-3740 |